YouTube Facebook LinkedIn Google+ Twitter Xingrss  

News Blast


Oct 17, 2005

ONE STOP
Caliper Life Sciences announced an agreement to acquire NovaScreen Biosciences for $22 million, providing “one-stop-shopping for drug discovery instrumentation, and screening and assay development services,” according to Caliper.

NEW STRAND
Strand Life Sciences (formerly Strand Genomics), of Bangalore, India, launched an in silico predictive ADME/Tox tool, admetis. “admetis couples prebuilt models with a workflow-based modeling platform,” said Kas Subramanian, Strand’s CSO.

EMERGING
Pharmagene, a British human-tissue-based drug discovery company, has agreed to the terms of a merger with Asterand, a private U.S. company focused on human tissue supply and services. The directors of Pharmagene believe that the merger will create a leading company in human tissue supply and research services.

APPOINTMENT
William Emhiser was appointed CEO of Whatman, following the acquisition of Schleicher & Schuell, a German analytical chemistry supplier, which made Whatman the world’s number 3 provider of separations technology to the life sciences industry.

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.